VPS34 inhibition decreases intracellular levels of cholesteryl-esters, blocks cholesterol uptake and enhances lysosomal degradation of LDLR. حسب Marek J. Kobylarz (9292599)

Detoxifying enzyme activities of slug larvae and adults treated with LC₅₀ for 24 and 48 h, respectively. حسب Haojun Li (11007721)

Protective enzyme activities of slug larvae and adults treated with LC₅₀ for 24 and 48 h, respectively. حسب Haojun Li (11007721)

Dose response of airways to Methacholine shows a decreased contractility in <i>GSTCD</i>^-/- mouse lungs following LPS treatment. حسب Bo Liu (127343)

Knockdown of MRN complex decreases HBV cccDNA level. حسب Kaitao Zhao (3617825)

Knockdown of MRN complex decreases HBV cccDNA level. حسب Kaitao Zhao (3617825)

Impaired Ubr5 function results in increased canonical and decreased non-canonical HH signalling. حسب David Mellis (2833469)

Cardiac-specific p38γ/δ^act overexpression decreases cardiac glycogen storage and lipid accumulation. حسب Ayelén M. Santamans (5487941)

The fraction of predicted heterozygotes that are set to “No Call” by RHA decreases as the size of the heterozygote cluster increases. حسب Orna Mizrahi-Man (42539)

Data_Sheet_1_Effectiveness of non-pharmaceutical interventions in nine fields of activity to decrease SARS-CoV-2 transmission (Spain, September 2020–May 2021).PDF حسب Inés Barbeito (5864351)

"…In a reduced model with seven fields, culture and leisure no longer had a significant effect while ceremonies decreased transmission by 5% (0.95; 0, 0.96). …"

HPD 1466 decreases empty capsid accumulation in cells replicating HBV. حسب Daniel P. Bradley (10306893)

GSK343 decreased tumor stemness. حسب Laura V. Bownes (10276762)

"…(C) COA6 cells were treated with GSK343 (0, 5 μM) for 72 hours. qPCR demonstrated a significant decrease in mRNA abundance of known stemness markers Oct4, Nanog, and Sox2 following GSK343 treatment compared to untreated cells. …"

Chemical Analysis and Antidiabetic Potential of a Decoction from <i>Stevia serrata</i> Roots حسب Sofía Padilla-Mayne (17027483)

"…Glycoside <b>2</b> (5 and 50 mg/kg) decreased blood glucose levels and the postprandial peak during oral glucose and insulin tolerance tests in STZ-hyperglycemic mice. …"

Effects of TGF-β1 on the expression of fibrosis indicators in HBdSMCs and the effects of MEL on the expression of fibrosis indicators in HBdSMCs induced by TGF-β1. حسب Yang Zhang (30734)

TG6-44 treatment leads to decrease in A/X31-induced cell death in THP-1 cells. حسب Juan A. De La Cruz (11154187)

Cancellous bone microarchitecture assessed by μCT of the distal femur from 8.5–9 week old <i>Notch3</i>^{<i>em1Ecan</i>} mutant (gray bars) male mice and sex-matched litter... حسب Ernesto Canalis (516050)

الموضوعات:

Cortical bone microarchitecture assessed by μCT of the mid-diaphyseal femur from 8.5–9week old <i>Notch3</i>^{<i>em1Ecan</i>} mutant (gray bars) male mice and sex-matched l... حسب Ernesto Canalis (516050)

الموضوعات:

Advancing the science of NOWS research. حسب Sarah E. Maylott (14560785)

"…<div><p>Every 15 minutes in the US, an infant exposed to opioids is born. Approximately 50% of these newborns will develop Neonatal Opioid Withdrawal Syndrome (NOWS) within 5 days of birth. …"

Protocol measures. حسب Sarah E. Maylott (14560785)

"…<div><p>Every 15 minutes in the US, an infant exposed to opioids is born. Approximately 50% of these newborns will develop Neonatal Opioid Withdrawal Syndrome (NOWS) within 5 days of birth. …"

Cry variables. حسب Sarah E. Maylott (14560785)

"…<div><p>Every 15 minutes in the US, an infant exposed to opioids is born. Approximately 50% of these newborns will develop Neonatal Opioid Withdrawal Syndrome (NOWS) within 5 days of birth. …"